| 2006 年 | 2007 年 | 2008 年 | 2009 年 | 2010 年 |
| 2011 年 | 2012 年 | 2013 年 | 2014 年 | 2015 年 |
| 2016 年 | 2017 年 | 2018 年 | 2019 年 | 2020 年 |
| 2021 年 | 2022 年 | 2023 年 | 2024 年 |
※ 英文原著論文のみ掲載しています。
【 2021年 】
- Fujii H.
Is Oxidative Stress a Key Player for Progression of Cardiovascular Disease in Dialysis Patients?
Atheroscler Thromb*. 2021; 28(3): 227-229. - Fujii H, Kono K, Watanabe K, Goto S, Nishii T, Kono A, Nishi S.
Evaluation of aortic calcification using a three-dimensional volume-rendering method in patients with end-stage kidney disease.
J Bone Miner Metab. 2021;39(3):439-445. - Kono K, Fujii H, Watanabe K, Goto S, Nishi S.
Relationship between parathyroid hormone and renin-angiotensin-aldosterone system in hemodialysis patients with secondary hyperparathyroidism.
J Bone Miner Metab. 2021;39(2):230-236. - Nagai-Sangawa M, Fukunaga A, Takeuchi C, Nishiyama S, Horikawa T, Nagano C, Nozu K, Fujii H, Nishigori C.
Beneficial screening of Fabry disease in patients with hypohidrosis.
J Dermatol. 2021, Online ahead of print. - Isaka Y, Hamano T, Fujii H, Tsujimoto Y, Koiwa F, Sakaguchi Y, Tanaka R, Tomiyama N, Tatsugami F, Teramukai S.
Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients.
J Am Soc Nephrol. 2021;32(3):723-735. - Rossanti R, Nozu K, Fukunaga A, Nagano C, Horinouchi T, Yamamura T, Sakakibara N, Minamikawa S, Ishiko S, Aoto Y, Okada E, Ninchoji T, Kato N, Maruyama S, Kono K, Nishi S, Iijima K, Fujii H.
X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay.
Clin Exp Nephrol. 2021;25(11):1224-1230. - Shoji T, Nakatani S, Kabata D, Mori K, Shintani A, Yoshida H, Takahashi K, Ota K, Fujii H, Ueda S, Nishi S, Nakatani T, Yoshiyama M, Goto K, Hamada T, Imanishi M, Ishimura E, Kagitani S, Kato Y, Kumeda Y, Maekawa K, Matsumura T, Nagayama H, Obi Y, Ohno Y, Sai Y, Sakurai M, Sasaki S, Shidara K, Shoji S, Tsujimoto Y, Yamakawa K, Yasuda H, Yodoi S, Inaba M, Emoto M.
Comparative Effects of Etelcalcetide and Maxacalcitol on Serum Calcification Propensity in Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Clin J Am Soc Nephrol. 2021;16(4):599-612. - Tsuruya K, Hayashi T, Yamamoto H, Hase H, Nishi S, Yamagata K, Nangaku M, Wada T, Uemura Y, Ohashi Y, Hirakata H; RADIANCE-CKD Study Investigators.
Renal prognoses by different target hemoglobin levels achieved by epoetin beta pegol dosing to chronic kidney disease patients with hyporesponsive anemia to erythropoiesis-stimulating agent: a multicenter open-label randomized controlled study.
Clin Exp Nephrol. 2021;25(5):456-466. - Saeki T, Kawano M, Nagasawa T, Ubara Y, Taniguchi Y, Yanagita M, Nishi S, Nagata M, Hisano S, Yamaguchi Y, Nomura H, Saito T, Nakashima H.
Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version.
Clin Exp Nephrol. 2021;25(2):99-109. - Saeki T, Nagasawa T, Ubara Y, Taniguchi Y, Yanagita M, Nishi S, Nagata M, Yamaguchi Y, Saito T, Nakashima H, Kawano M.
Validation of the 2019 ACR/EULAR criteria for IgG4-related disease in a Japanese kidney disease cohort: a multicentre retrospective study by the IgG4-related kidney disease working group of the Japanese Society of Nephrology.
Ann Rheum Dis. 2021;80(7):956-957. - Yamanouchi M, Furuichi K, Shimizu M, Toyama T, Yamamura Y, Oshima M, Kitajima S, Hara A, Iwata Y, Sakai N, Oba Y, Matsuoka S, Ikuma D, Mizuno H, Suwabe T, Hoshino J, Sawa N, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ueda Y, Nishi S, Yokoyama H, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Makino H, Matsuo S, Ubara Y, Wada T; Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development.
Serum hemoglobin concentration, as a reflection of renal fibrosis, and risk of renal decline in early-stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
Nephrol Dial Transplant. 2021, Online ahead of print. - Nishi S, Goto S, Mieno M, Yagisawa T, Yuzawa K.
The Modified Chronic Kidney Disease Epidemiology Collaboration Equation for the Estimated Glomerular Filtration Rate Is Better Associated with Comorbidities than Other Equations in Living Kidney Donors in Japan.
Intern Med. 2021;60(17):2757-2764. - Yamanouchi M, Furuichi K, Hoshino J, Toyama T, Shimizu M, Yamamura Y, Oshima M, Kitajima S, Hara A, Iwata Y, Sakai N, Oba Y, Matsuoka S, Ikuma D, Mizuno H, Suwabe T, Sawa N, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ueda Y, Nishi S, Yokoyama H, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Makino H, Matsuo S, Ubara Y, Wada T; Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development.
Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney disease.
BMJ Open Diabetes Res Care. 2021;9(1):e002241. - Urushihara M, Sato H, Shimizu A, Sugiyama H, Yokoyama H, Hataya H, Matsuoka K, Okamoto T, Ogino D, Miura K, Hamada R, Hibino S, Shima Y, Yamamura T, Kitamoto K, Ishihara M, Konomoto T, Hattori M; the Committee for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology.
Clinical and histological features in pediatric and adolescent/young adult patients with renal disease: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR).
Clin Exp Nephrol. 2021;25(9):1018-1026. - Okamoto K, Fujii H, Watanabe K, Goto S, Kono K, Nishi S.
Changes of FGF23 and the renin-angiotensin-system in male mouse models of chronic kidney disease and cardiac hypertrophy.
J Endocr Soc. 2021; 6(2): bvab187.
